Defiance ETFs Launched NVOX, The World's First Single-stock Leveraged ETF For The Pharmaceutical Stock Novo Nordisk

Benzinga · Dec 3 19:03

As the weight loss market continues to expand and Novo Nordisk is a key provider in that space, NVOX offers retail investors 2X daily long leveraged exposure to the change in the daily share price of Novo Nordisk without the need for a margin account.

This provides a unique tool for tactical traders. NVOX does not invest directly in Novo Nordisk and has a higher degree of risk due to tracking a single stock.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Defiance ETFs Launched NVOX, The World's First Single-stock Leveraged ETF For The Pharmaceutical Stock Novo Nordisk

Risk Disclaimer